Cognitive dysfunction and chemotherapy: neuropsychological findings in perspective.

Clinical breast cancer

Volumn 3 Suppl 3, Issue , 2002, Pages

  Schagen, Sanne B ^a   Muller, Martin J ^a   Boogerd, Willem ^a   Van Dam, Frits S A M ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; BREAST TUMOR; CENTRAL NERVOUS SYSTEM; CHEMICALLY INDUCED DISORDER; COGNITIVE DEFECT; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG EFFECT; FEMALE; HOSPITALIZATION; HUMAN; INCIDENCE; MASTECTOMY; METHODOLOGY; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TEST; PROGNOSIS; REVIEW; RISK ASSESSMENT;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CENTRAL NERVOUS SYSTEM; CHEMOTHERAPY, ADJUVANT; COGNITION DISORDERS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INCIDENCE; MASTECTOMY; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TESTS; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX;

MLCS; MLOWN;

EID: 0036985805     PISSN: 15268209     EISSN: None     Source Type: Journal    
DOI: 10.3816/cbc.2002.s.020     Document Type: Review

References (46)